Immunization of Women With Diphtheria and Tetanus Toxoids Combined With Acellular Pertussis (Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the Potential for Immunological Protection for the Neonate

Trial Profile

Immunization of Women With Diphtheria and Tetanus Toxoids Combined With Acellular Pertussis (Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the Potential for Immunological Protection for the Neonate

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs DTaP vaccine (Primary) ; Diphtheria-tetanus vaccine
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Jun 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2016.
    • 01 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Feb 2016, according to ClinicalTrials.gov record.
    • 23 Feb 2015 Planned End Date changed from 1 Jun 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top